Intranasal naloxone compositions and methods of making and using same
US9192570B2 · kind B2 · utility
24Cited by
37References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2014 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | Dec 19, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.